Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

5.98
Delayed Data
As of Apr 28
 -0.17 / -2.76%
Today’s Change
3.50
Today|||52-Week Range
6.64
+30.00%
Year-to-Date

Today’s Trading

Previous close6.15
Today’s open6.15
Day’s range5.87 - 6.15
Volume171,533
Average volume (3 months)447,479
Market cap$278.4M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+38.20%
Earnings growth (this year)-1.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.02%
P/E ratioNM
Price/Sales37.33
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...-0.01-0.05%
NERVMinerva Neuroscience...-0.10-1.30%
ZGNXZogenix Inc0.000.00%
OCULOcular Therapeutix I...+0.07+0.71%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$5.7M
Annual profit (last year)-$76.4M
Net profit margin-1,339.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts